Search results for “Myeloid Malignancy” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 120 patents, we discovered top 15 key players by total patent application. Das CeMM - Forschungszentrum für Molekulare Medizin GmbH, Gammadelta Therapeutics Ltd., ModernaTX, Inc. are dominant in this area. They take 40.83% of the total patent filing.
Das CeMM - Forschungszentrum für Molekulare Medizin GmbH
Wien, Austria
Patent: 25
STARTUP
Gammadelta Therapeutics Ltd.
United Kingdom
Patent: 10
ModernaTX, Inc.
Massachusetts, United States
Patent: 7
Argenx BV
Belgium
Patent: 7
Yeda Research & Development Co. Ltd.
Israel
Patent: 5
Seagen Inc.
Washington, United States
Patent: 3
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 3
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 2
Institut National de la Santé et de la Recherche Médicale
France
Patent: 2
Ecole Nationale Veterinaire De Toulouse
France
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 10 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Gammadelta Therapeutics Ltd.
United Kingdom
Patent: 10
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 97 patents applied in the last 5 years. We discover 23 most active companies in this area. The fast-growing University of Bern, Gammadelta Therapeutics Ltd., Argenx BV take 31.96% of patent filing during this period.
University of Bern
Bern, Switzerland
Patent: 14
STARTUP
Gammadelta Therapeutics Ltd.
United Kingdom
Patent: 10
Argenx BV
Belgium
Patent: 7
ModernaTX, Inc.
Massachusetts, United States
Patent: 7
Regents of the University of Colorado
Colorado, United States
Patent: 6
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 6
IU Ventures
Indiana, United States
Patent: 5
University of Minnesota
Minnesota, United States
Patent: 5
Yeda Research & Development Co. Ltd.
Israel
Patent: 5
Das CeMM - Forschungszentrum für Molekulare Medizin GmbH
Wien, Austria
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 97 patents in last 5 years, we discover 22 new entrants. University of Bern, Gammadelta Therapeutics Ltd., Argenx BV are the most active new entrants in this area.
University of Bern
Bern, Switzerland
Patent: 14
STARTUP
Gammadelta Therapeutics Ltd.
United Kingdom
Patent: 10
Argenx BV
Belgium
Patent: 7
ModernaTX, Inc.
Massachusetts, United States
Patent: 7
Regents of the University of Colorado
Colorado, United States
Patent: 6
H. Lee Moffitt Cancer Center & Research Institute, Inc.
United States
Patent: 6
IU Ventures
Indiana, United States
Patent: 5
University of Minnesota
Minnesota, United States
Patent: 5
Yeda Research & Development Co. Ltd.
Israel
Patent: 5
Seagen Inc.
Washington, United States
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 41 patents, we discovered top 9 universities and scientific research institutions by total patent application. University of Bern, Regents of the University of Colorado, University of Minnesota are dominant in this area. They take 63.41% of the total patent filing.
University of Bern
Bern, Switzerland
Patent: 14
Regents of the University of Colorado
Colorado, United States
Patent: 6
University of Minnesota
Minnesota, United States
Patent: 5
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 3
Northwestern University
Illinois, United States
Patent: 3
Institut Gustave Roussy EURL
France
Patent: 3
Université Toulouse III - Paul Sabatier
France
Patent: 2
Duke University
North Carolina, United States
Patent: 1
Université de Paris
France
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: